Janux Therapeutics, Inc.JANXNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+123.9%
5Y CAGR+273.4%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+123.9%/yr
Annual compound
5Y CAGR
+273.4%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
726.2x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $9.44M | +358.3% |
| 2024 | $2.06M | +5.4% |
| 2023 | $1.96M | +132.5% |
| 2022 | $841000.00 | - |
| 2021 | $0.00 | -100.0% |
| 2020 | $13000.00 | +116.7% |
| 2019 | $6000.00 | - |